Cargando…

Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models

Col4a3(−/−) Alport mice serve as an animal model for renal fibrosis. MicroRNA-21 (miR-21) expression has been shown to be increased in the kidneys of Alport syndrome patients. Here, we investigated the nephroprotective effects of Lademirsen anti-miR-21 therapy. We used a fast-progressing Col4a3(−/−)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubel, Diana, Boulanger, Joseph, Craciun, Florin, Xu, Ethan Y., Zhang, Yanqin, Phillips, Lucy, Callahan, Michelle, Weber, William, Song, Wenping, Ngai, Nicholas, Bukanov, Nikolay O., Shi, Xingyi, Hariri, Ali, Husson, Hervé, Ibraghimov-Beskrovnaya, Oxana, Liu, Shiguang, Gross, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869926/ https://www.ncbi.nlm.nih.gov/pubmed/35203245 http://dx.doi.org/10.3390/cells11040594

Ejemplares similares

Polycystic kidney diseases: From molecular discoveries to targeted therapeutic strategies
por: Ibraghimov-Beskrovnaya, O., et al.
Publicado: (2007)

Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD
por: Rogers, Kelly A., et al.
Publicado: (2016)

Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome
por: Rubel, Diana, et al.
Publicado: (2021)

Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease
por: Natoli, Thomas A., et al.
Publicado: (2012)

CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD
por: Bukanov, Nikolay O., et al.
Publicado: (2012)

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease
por: Baccam, Gabriel C., et al.
Publicado: (2022)

Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis
por: Husson, Hervé, et al.
Publicado: (2016)

Genotype–phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2021)

Correction of cilia structure and function alleviates multi-organ pathology in Bardet–Biedl syndrome mice
por: Husson, Hervé, et al.
Publicado: (2020)

Inhibition of TGF‐β Increases Bone Volume and Strength in a Mouse Model of Osteogenesis Imperfecta
por: Greene, Benjamin, et al.
Publicado: (2021)

Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients
por: Gross, Oliver, et al.
Publicado: (2012)

Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome
por: Gross, Oliver, et al.
Publicado: (2017)

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012)

Alport Syndrome With Kidney Cysts Is Still Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2021)

Characterization of Sensorineural Hearing Loss in Children with Alport Syndrome
por: Boeckhaus, Jan, et al.
Publicado: (2020)

Editorial: Collagen IV nephropathies: Alport syndrome and beyond
por: Borza, Dorin-Bogdan, et al.
Publicado: (2022)

Women and Alport syndrome
por: Rheault, Michelle N.
Publicado: (2011)

Alport's Syndrome in Pregnancy
por: Mehta, Suchita, et al.
Publicado: (2013)

The 2014 International Workshop on Alport Syndrome
por: Miner, Jeffrey H, et al.
Publicado: (2014)

Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice
por: Petrova, Darinka Todorova, et al.
Publicado: (2014)

Sindrome de Alport : revisión bibliográfica
por: Velasco Bello, Fernando Mario
Publicado: (1994)

Alport syndrome: facts and opinions
por: Kashtan, Clifford
Publicado: (2017)

Genetic diagnosis of Alport syndrome
por: Cheong, Hae Il
Publicado: (2019)

Alport Syndrome Classification and Management
por: Warady, Bradley A., et al.
Publicado: (2020)

Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022)

Auditory Perception in Alport’s Syndrome
por: Viveiros, Carla Mherlyn, et al.
Publicado: (2015)

Clinical trial recommendations for potential Alport syndrome therapies
por: Weinstock, B. André, et al.
Publicado: (2020)

The 2019 and 2021 International Workshops on Alport Syndrome
por: Daga, Sergio, et al.
Publicado: (2022)

Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children
por: Li, Baihong, et al.
Publicado: (2018)

The importance of clinician, patient and researcher collaborations in Alport syndrome
por: Rheault, Michelle N., et al.
Publicado: (2019)

mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Anterior lenticonus associated with Alport syndrome
por: Jinagal, Jitender, et al.
Publicado: (2018)

Pulmonary calcinosis associated with Alport syndrome
por: Mismetti, Valentine, et al.
Publicado: (2022)

Alport Syndrome: A Comprehensive Review
por: Adone, Avanti, et al.
Publicado: (2023)

X-linked Alport syndrome: pathogenic variant features and further auditory genotype-phenotype correlations in males
por: Zhang, Xiao, et al.
Publicado: (2018)

Author Correction: mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

Molecular testing for adult type Alport syndrome
por: Pont-Kingdon, Genevieve, et al.
Publicado: (2009)

Podocyte Depletion in Thin GBM and Alport Syndrome
por: Wickman, Larysa, et al.
Publicado: (2016)

It is an Alport syndrome, not a simple hypertensive retinopathy
por: Gadde, Aruna Kumari, et al.
Publicado: (2018)

Glomerular endothelial cell heterogeneity in Alport syndrome
por: Soloyan, Hasmik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_djmdtu9hv8tcinckik11slabiu